Literature DB >> 24093633

Caseload as a factor for outcome in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Hieronymus D Boogaarts1, Martinus J van Amerongen, Joost de Vries, Gert P Westert, André L M Verbeek, J André Grotenhuis, Ronald H M A Bartels.   

Abstract

OBJECT: Increasing evidence exists that treatment of complex medical conditions in high-volume centers is found to improve outcome. Patients with subarachnoid hemorrhage (SAH), a complex disease, probably also benefit from treatment at a high-volume center. The authors aimed to determine, based on published literature, whether a higher hospital caseload is associated with improved outcomes of patients undergoing treatment after aneurysmal subarachnoid hemorrhage.
METHODS: The authors identified studies from MEDLINE, Embase, and the Cochrane Library up to September 28, 2012, that evaluated outcome in high-volume versus low-volume centers in patients with SAH who were treated by either clipping or endovascular coiling. No language restrictions were set. The compared outcome measure was in-hospital mortality. Mortality in studies was pooled in a random effects meta-analysis. Study quality was reported according to the GRADE (Grading of Recommendations Assessment, Development and Evaluation) criteria.
RESULTS: Four articles were included in this analysis, representing 36,600 patients. The quality of studies was graded low in 3 and very low in 1. Meta-analysis using a random effects model showed a decrease in hospital mortality (OR 0.77 [95% CI 0.60-0.97]; p = 0.00; I(2) = 91%) in high-volume hospitals treating SAH patients. Sensitivity analysis revealed the relative weight of the 1 low-quality study. Removal of the study with very low quality increased the effect size of the meta-analysis to an OR of 0.68 (95% CI 0.56-0.84; p = 0.00; I(2) = 86%). The definition of hospital volume differed among studies. Cutoffs and dichotomizations were used as well as division in quartiles. In 1 study, low volume was defined as 9 or fewer patients yearly, whereas in another it was defined as fewer than 30 patients yearly. Similarly, 1 study defined high volume as more than 20 patients annually, and another defined it as more than 50 patients a year. For comparability between studies, recalculation was done with dichotomized data if available. Cross et al., 2003 (low volume ≤ 18, high volume ≥ 19) and Johnston, 2000 (low volume ≤ 31, high volume ≥ 32) provided core data for recalculation. The overall results of this analysis revealed an OR of 0.85 (95% CI 0.72-0.99; p = 0.00; I(2) = 87%).
CONCLUSIONS: Despite the shortcomings of this study, the mortality rate was lower in hospitals with a larger caseload. Limitations of the meta-analysis are the not uniform cutoff values and uncertainty about case mix.

Entities:  

Mesh:

Year:  2013        PMID: 24093633     DOI: 10.3171/2013.9.JNS13640

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  13 in total

1.  Mechanical Thrombectomy-Ready Comprehensive Stroke Center Requirements and Endovascular Stroke Systems of Care: Recommendations from the Endovascular Stroke Standards Committee of the Society of Vascular and Interventional Neurology (SVIN).

Authors:  Joey D English; Dileep R Yavagal; Rishi Gupta; Vallabh Janardhan; Osama O Zaidat; Andrew R Xavier; Raul G Nogueira; Jawad F Kirmani; Tudor G Jovin
Journal:  Interv Neurol       Date:  2016-02-19

2.  Current practice in neurocritical care of patients with subarachnoid haemorrhage and severe traumatic brain injury : Results of the Austrian Neurosurvey Study.

Authors:  Günther Herzer; Udo Illievich; Wolfgang G Voelckel; Helmut Trimmel
Journal:  Wien Klin Wochenschr       Date:  2016-07-12       Impact factor: 1.704

3.  Impact of hospital case-volume on subarachnoid hemorrhage outcomes: A nationwide analysis adjusting for hemorrhage severity.

Authors:  Barret Rush; Kali Romano; Mohammad Ashkanani; Robert C McDermid; Leo Anthony Celi
Journal:  J Crit Care       Date:  2016-09-14       Impact factor: 3.425

4.  Advanced Age and Post-Acute Care Outcomes After Subarachnoid Hemorrhage.

Authors:  Corey R Fehnel; William B Gormley; Hormuzdiyar Dasenbrock; Yoojin Lee; Faith Robertson; Alexandra G Ellis; Vincent Mor; Susan L Mitchell
Journal:  J Am Heart Assoc       Date:  2017-10-24       Impact factor: 5.501

Review 5.  Influence of hospital volume on nephrectomy mortality and complications: a systematic review and meta-analysis stratified by surgical type.

Authors:  Ray C J Hsu; Theodosia Salika; Jonathan Maw; Georgios Lyratzopoulos; Vincent J Gnanapragasam; James N Armitage
Journal:  BMJ Open       Date:  2017-09-05       Impact factor: 2.692

6.  Treatment Modality and Quality Benchmarks of Aneurysmal Subarachnoid Hemorrhage at a Comprehensive Stroke Center.

Authors:  Wengui Yu; Tapan Kavi; Tamara Majic; Kimberly Alva; Asma Moheet; Patrick Lyden; Wouter Schievink; Gregory Lekovic; Michael Alexander
Journal:  Front Neurol       Date:  2018-03-15       Impact factor: 4.003

7.  Association between volume of surgery for acute hemorrhagic stroke and mortality.

Authors:  Bo Yeon Lee; Shin Ha; Yo Han Lee
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

8.  Association of hospital and surgeon volume with mortality following major surgical procedures: Meta-analysis of meta-analyses of observational studies.

Authors:  Hiroshi Hoshijima; Zen'ichiro Wajima; Hiroshi Nagasaka; Toshiya Shiga
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

Review 9.  Aneurysmal Subarachnoid Hemorrhage: the Last Decade.

Authors:  Sean N Neifert; Emily K Chapman; Michael L Martini; William H Shuman; Alexander J Schupper; Eric K Oermann; J Mocco; R Loch Macdonald
Journal:  Transl Stroke Res       Date:  2020-10-19       Impact factor: 6.829

10.  The Impact of Surgical Experience on Major Intraoperative Aneurysm Rupture and Their Consequences on Outcome: A Multivariate Analysis of 538 Microsurgical Clipping Cases.

Authors:  Chung-En Hsu; Tzu-Kang Lin; Ming-Hsueh Lee; Shih-Tseng Lee; Chen-Nen Chang; Chih-Lung Lin; Yung-Hsin Hsu; Yin-Cheng Huang; Tsung-Che Hsieh; Chee-Jen Chang
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.